Who invested in Svelte Medical Systems?
Svelte Medical Systems's investors include CNF Investments, New Science Venture, West Health Investment Fund and Apjohn Ventures Fund, LP.
United States · Growth startup
8 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$75Mraised across 8 rounds since 2009, from 8 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding recordSEC filing: $27M sold, first sale Oct 2013
Reported by finsmes.comSEC filing: $18M sold, first sale Oct 2013
No investor was named in the report.
Reported by sec.govSEC filing: $1.8M sold, first sale Apr 2013
No investor was named in the report.
Reported by sec.govSEC filing: $5.0M sold, first sale Jun 2012
No investor was named in the report.
Reported by sec.govSEC filing: $19M sold, first sale Dec 2011
No investor was named in the report.
Reported by sec.govSEC filing: $4.5M sold, first sale Oct 2010
Reported by finsmes.comSEC filing: $6.0M sold, first sale Nov 2009
No investor was named in the report.
From a historical funding recordSEC filing: $6.3M sold, first sale Jan 2009
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Svelte Medical Systems's investors include CNF Investments, New Science Venture, West Health Investment Fund and Apjohn Ventures Fund, LP.
Svelte Medical Systems has raised $75M across 8 rounds since 2009.
Svelte Medical Systems's most recent round was a Growth of $5.0M in Mar 2014.
Svelte Medical Systems's largest round on record is $22M (Growth), in Oct 2013.
Svelte Medical Systems's first round on record, in Nov 2009, was backed by CNF Investments and Apjohn Ventures Fund, LP.
Svelte Medical Systems's latest named round is a Growth, in Mar 2014.
Svelte Medical Systems is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.